| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 Activ-3/Tico Ly-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 329 | 2021 |
| Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression S Swaminathan, K Suzuki, N Seddiki, W Kaplan, MJ Cowley, CL Hood, ... The Journal of Immunology 188 (12), 6238-6246, 2012 | 176 | 2012 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 124 | 2022 |
| Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific K Suzuki, T Ishida, M Yamagishi, C Ahlenstiel, S Swaminathan, K Marks, ... RNA biology 8 (6), 1035-1046, 2011 | 59 | 2011 |
| Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels: a randomized controlled trial ACTIV-3/TICO Bamlanivimab Study Group* Annals of internal medicine 175 (2), 234-243, 2022 | 57 | 2022 |
| Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: A randomised, double-blind, phase 3 trial TL Holland, AA Ginde, R Paredes, TA Murray, N Engen, G Grandits, ... The Lancet Respiratory Medicine 10 (10), 972-984, 2022 | 54 | 2022 |
| Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients EE Ilett, M Jørgensen, M Noguera-Julian, JC Nørgaard, G Daugaard, ... Blood advances 4 (22), 5797-5809, 2020 | 50 | 2020 |
| mi RNA s and HIV: unforeseen determinants of host‐pathogen interaction S Swaminathan, DD Murray, AD Kelleher Immunological reviews 254 (1), 265-280, 2013 | 50 | 2013 |
| The role of microRNAs in HIV-1 pathogenesis and therapy S Swaminathan, DD Murray, AD Kelleher Aids 26 (11), 1325-1334, 2012 | 49 | 2012 |
| Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial MN Polizzotto, J Nordwall, AG Babiker, A Phillips, DM Vock, N Eriobu, ... The Lancet 399 (10324), 530-540, 2022 | 42 | 2022 |
| Sepsis: Personalized Medicine Utilizing ‘Omic’Technologies—A Paradigm Shift? TS Itenov, DD Murray, JUS Jensen Healthcare 6 (3), 111, 2018 | 28 | 2018 |
| Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals DD Murray, K Suzuki, M Law, J Trebicka, J Neuhaus Nordwall, M Johnson, ... Scientific Reports 7 (1), 10934, 2017 | 27 | 2017 |
| The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome M Gelpi, F Mikaeloff, AD Knudsen, R Benfeitas, S Krishnan, SS Akusjärvi, ... Aging (Albany NY) 13 (19), 22732, 2021 | 22 | 2021 |
| Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized patients using 16S rRNA gene and shotgun metagenomic sequencing EE Ilett, M Jørgensen, M Noguera-Julian, G Daugaard, DD Murray, ... Scientific Reports 9 (1), 13351, 2019 | 21 | 2019 |
| Association between single-nucleotide polymorphisms in HLA alleles and human immunodeficiency virus type 1 viral load in demographically diverse, antiretroviral therapy–naive … C Ekenberg, MH Tang, AG Zucco, DD Murray, CR MacPherson, X Hu, ... The Journal of infectious diseases 220 (8), 1325-1334, 2019 | 20 | 2019 |
| Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with … DD Murray, AG Babiker, JV Baker, CE Barkauskas, SM Brown, CC Chang, ... Clinical Trials 19 (1), 52-61, 2022 | 19 | 2022 |
| Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients EE Ilett, M Helleberg, J Reekie, DD Murray, SM Wulff, MP Khurana, ... Open Forum Infectious Diseases 6 (4), ofz086, 2019 | 18 | 2019 |
| Biomarkers of acute lung injury the individualized approach: for phenotyping, risk stratification and treatment surveillance DD Murray, TS Itenov, P Sivapalan, JV Eklöf, FS Holm, P Schuetz, ... Journal of clinical medicine 8 (8), 1163, 2019 | 17 | 2019 |
| Efficacy and safety of ensovibep for adults hospitalized with COVID-19: a randomized controlled trial ACTIV-3/TICO Study Group* Annals of internal medicine 175 (9), 1266-1274, 2022 | 16 | 2022 |
| Integrative lipidomics and metabolomics for system-level understanding of the metabolic syndrome in long-term treated HIV-infected individuals S Olund Villumsen, R Benfeitas, AD Knudsen, M Gelpi, J Høgh, ... Frontiers in Immunology 12, 742736, 2022 | 16 | 2022 |
